Healthcare Sector Stocks
The Healthcare sector has a total of 1044 stocks, with a combined market cap of $8.97 trillion, total revenue of $4.6 trillion and a weighted average PE ratio of 50.24.
Market Cap
8.97T
Revenue
4.6T
Profits
178.51B
PE Ratio
50.24
Profit Margin
3.88%
Dividend Yield
0.38%
1044 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | 3.27% | 1,334,803 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 653.88B | 0.80% | 2,711,290 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 466.55B | -0.40% | 1,591,942 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 365.49B | 0.04% | 2,827,766 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 334.34B | 0.32% | 2,419,842 | 450.53B |
| 6 | NVS | Novartis AG | 270.93B | 0.48% | 1,259,238 | 56.69B |
| 7 | TMO | Thermo Fisher Scientific Inc. | 248.91B | 1.19% | 1,060,146 | 46.34B |
| 8 | AMGN | Amgen Inc. | 219.11B | -0.20% | 687,008 | 38.10B |
| 9 | GILD | Gilead Sciences, Inc. | 187.03B | -0.35% | 2,505,085 | 30.46B |
| 10 | ABT | Abbott Laboratories | 175.89B | -1.78% | 2,066,215 | 46.59B |
| 11 | NVO | Novo Nordisk A/S | 170.00B | 0.29% | 13,008,517 | 50.34B |
| 12 | PFE | Pfizer Inc. | 162.16B | 0.96% | 19,183,651 | 63.70B |
| 13 | DHR | Danaher Corporation | 156.20B | 0.29% | 3,110,889 | 25.11B |
| 14 | ISRG | Intuitive Surgical, Inc. | 141.57B | 0.61% | 725,234 | 11.03B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 132.03B | 0.88% | 365,645 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 124.44B | -0.38% | 4,467,779 | 49.19B |
| 17 | MDT | Medtronic plc | 113.65B | -0.50% | 4,832,886 | 37.54B |
| 18 | CVS | CVS Health Corporation | 108.41B | -1.28% | 3,380,078 | 412.65B |
| 19 | SYK | Stryker Corporation | 103.74B | -1.08% | 936,491 | 25.84B |
| 20 | MCK | McKesson Corporation | 102.51B | -0.14% | 247,152 | 410.98B |
| 21 | GSK | GSK plc | 100.19B | -0.04% | 1,519,018 | 44.05B |
| 22 | SNY | Sanofi | 98.20B | -1.66% | 1,954,097 | 55.89B |
| 23 | HCA | HCA Healthcare, Inc. | 92.69B | -1.92% | 366,800 | 78.01B |
| 24 | ELV | Elevance Health, Inc. | 85.68B | -0.88% | 467,063 | 201.11B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 79.18B | -1.11% | 262,756 | 15.53B |
| 26 | MRNA | Moderna, Inc. | 73.54B | 1.15% | 8,683,790 | 2.23B |
| 27 | CI | The Cigna Group | 70.10B | -1.12% | 828,185 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 64.77B | 0.17% | 6,148,094 | 21.00B |
| 29 | COR | Cencora, Inc. | 59.60B | 0.02% | 510,068 | 332.77B |
| 30 | ARGX | argenx SE | 59.35B | 0.91% | 215,531 | 5.32B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.11B | -1.28% | 1,680,361 | 28.42B |
| 32 | NTRA | Natera, Inc. | 58.04B | 3.03% | 986,129 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 52.16B | 1.79% | 686,768 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 49.90B | -0.29% | 1,333,686 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 49.07B | -1.30% | 574,874 | 22.48B |
| 36 | A | Agilent Technologies, Inc. | 48.18B | 3.37% | 1,379,205 | 7.37B |
| 37 | TEVA | Teva Pharmaceutical Industries Limited | 46.19B | 1.61% | 2,991,608 | 17.32B |
| 38 | MDLN | Medline Inc. | 45.34B | 0.55% | 3,285,592 | 29.94B |
| 39 | HUM | Humana Inc. | 45.33B | 0.72% | 446,420 | 145.68B |
| 40 | IQV | IQVIA Holdings Inc. | 44.68B | 1.34% | 700,748 | 16.98B |
| 41 | VEEV | Veeva Systems Inc. | 44.14B | 0.68% | 608,758 | 3.46B |
| 42 | WAT | Waters Corporation | 41.97B | 1.57% | 471,031 | 4.64B |
| 43 | RVMD | Revolution Medicines, Inc. | 41.27B | 0.94% | 1,501,414 | - |
| 44 | ONC | BeOne Medicines AG | 40.84B | -1.59% | 275,354 | 6.13B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 40.51B | -1.49% | 114,564 | 4.55B |
| 46 | ILMN | Illumina, Inc. | 40.37B | 4.69% | 1,565,601 | 4.49B |
| 47 | HLN | Haleon plc | 39.89B | 1.21% | 13,109,969 | 14.80B |
| 48 | RPRX | Royalty Pharma plc | 33.48B | 1.01% | 810,263 | 2.54B |
| 49 | BIIB | Biogen Inc. | 33.40B | -0.65% | 426,114 | 10.03B |
| 50 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.11B | 0.37% | 417,000 | 4.80B |
| 51 | DXCM | DexCom, Inc. | 32.92B | -0.57% | 790,113 | 4.97B |
| 52 | ALC | Alcon Inc. | 31.65B | -1.28% | 777,089 | 10.86B |
| 53 | RMD | ResMed Inc. | 31.55B | -0.79% | 242,266 | 5.65B |
| 54 | CNC | Centene Corporation | 30.43B | -0.77% | 1,536,781 | 180.30B |
| 55 | MTD | Mettler-Toledo International Inc. | 30.30B | 1.34% | 125,391 | 4.13B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 29.62B | -0.79% | 1,336,617 | 21.27B |
| 57 | ZTS | Zoetis Inc. | 29.01B | -1.96% | 1,500,067 | 9.53B |
| 58 | WST | West Pharmaceutical Services, Inc. | 26.25B | -0.76% | 330,168 | 3.33B |
| 59 | ROIV | Roivant Sciences Ltd. | 26.23B | -1.36% | 2,782,966 | 7.53M |
| 60 | INSM | Insmed Incorporated | 26.21B | 1.40% | 1,271,039 | 1.14B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.07B | 1.37% | 416,047 | 11.56B |
| 62 | INCY | Incyte Corporation | 24.97B | -1.16% | 407,594 | 5.82B |
| 63 | LH | Labcorp Holdings Inc. | 24.80B | 0.61% | 236,176 | 14.35B |
| 64 | BNTX | BioNTech SE | 24.78B | 0.18% | 386,153 | 3.03B |
| 65 | PHG | Koninklijke Philips N.V. | 24.09B | -0.16% | 621,851 | 20.18B |
| 66 | GH | Guardant Health, Inc. | 23.80B | 0.58% | 1,446,198 | 1.18B |
| 67 | GMAB | Genmab A/S | 20.87B | -0.75% | 1,003,916 | 4.13B |
| 68 | STE | STERIS plc | 20.41B | -0.29% | 205,420 | 6.04B |
| 69 | THC | Tenet Healthcare Corporation | 20.35B | -1.43% | 187,188 | 21.81B |
| 70 | UTHR | United Therapeutics Corporation | 20.28B | -3.37% | 278,681 | 3.15B |
| 71 | VTRS | Viatris Inc. | 19.64B | -0.15% | 3,653,866 | 14.74B |
| 72 | MEDP | Medpace Holdings, Inc. | 17.31B | 0.49% | 132,676 | 2.78B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.00B | -1.91% | 894,801 | 8.51B |
| 74 | RVTY | Revvity, Inc. | 16.29B | 2.72% | 770,149 | 2.91B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 15.16B | -0.59% | 276,149 | 4.60B |
| 76 | SOLV | Solventum Corporation | 15.06B | 0.15% | 190,901 | 8.31B |
| 77 | ASND | Ascendis Pharma A/S | 14.86B | 1.42% | 546,604 | 1.20B |
| 78 | EXEL | Exelixis, Inc. | 14.21B | 1.08% | 626,210 | 2.44B |
| 79 | CRL | Charles River Laboratories International, Inc. | 14.11B | 6.58% | 698,003 | 4.00B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.10B | -0.58% | 453,820 | 3.37B |
| 81 | TEM | Tempus AI, Inc. | 14.00B | 1.33% | 6,760,301 | 1.43B |
| 82 | SMMT | Summit Therapeutics Inc. | 13.18B | 0.43% | 1,989,697 | - |
| 83 | ICLR | ICON Public Limited Company | 13.09B | 3.50% | 673,049 | 8.29B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.05B | 1.58% | 1,827,023 | 713.07M |
| 85 | HALO | Halozyme Therapeutics, Inc. | 12.93B | 1.31% | 1,111,435 | 1.66B |
| 86 | PEN | Penumbra, Inc. | 12.59B | 0.06% | 303,070 | 1.50B |
| 87 | CORT | Corcept Therapeutics Incorporated | 12.48B | 2.23% | 294,560 | 830.81M |
| 88 | BAX | Baxter International Inc. | 12.11B | -0.28% | 3,020,889 | 11.47B |
| 89 | EHC | Encompass Health Corporation | 12.08B | 0.18% | 294,545 | 6.21B |
| 90 | FMS | Fresenius Medical Care AG | 11.96B | -0.40% | 611,898 | 22.19B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.87B | 0.16% | 100,604 | 1.28B |
| 92 | BMRN | BioMarin Pharmaceutical Inc. | 11.85B | -1.58% | 577,183 | 3.41B |
| 93 | BTSG | BrightSpring Health Services, Inc. | 11.64B | 0.16% | 713,522 | 14.37B |
| 94 | TECH | Bio-Techne Corporation | 11.38B | 0.08% | 1,528,888 | 1.22B |
| 95 | DVA | DaVita Inc. | 11.26B | -3.60% | 342,377 | 14.01B |
| 96 | SNN | Smith & Nephew plc | 11.24B | -0.71% | 856,048 | 6.30B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.06B | -1.93% | 3,883,246 | 5.02B |
| 98 | TWST | Twist Bioscience Corporation | 11.00B | 10.70% | 2,032,668 | 431.80M |
| 99 | TXG | 10x Genomics, Inc. | 10.72B | 8.79% | 1,984,430 | 616.91M |
| 100 | RGEN | Repligen Corporation | 10.63B | 2.11% | 634,210 | 785.10M |
| 101 | UHS | Universal Health Services, Inc. | 10.49B | -1.84% | 281,352 | 18.11B |
| 102 | COO | The Cooper Companies, Inc. | 10.49B | -1.59% | 3,764,398 | 4.24B |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.44B | -0.61% | 1,261,832 | 3.50B |
| 104 | ALGN | Align Technology, Inc. | 10.36B | -1.61% | 285,913 | 4.14B |
| 105 | BIO | Bio-Rad Laboratories, Inc. | 10.26B | 1.29% | 145,774 | 2.59B |
| 106 | AVTR | Avantor, Inc. | 10.22B | 2.34% | 3,430,560 | 6.56B |
| 107 | AXSM | Axsome Therapeutics, Inc. | 10.18B | 0.49% | 156,719 | 776.57M |
| 108 | KRYS | Krystal Biotech, Inc. | 10.16B | 0.44% | 81,458 | 440.48M |
| 109 | ENSG | The Ensign Group, Inc. | 10.05B | -0.87% | 66,765 | 5.49B |
| 110 | GMED | Globus Medical, Inc. | 9.96B | 0.26% | 672,776 | 3.14B |
| 111 | MOH | Molina Healthcare, Inc. | 9.92B | 0.54% | 211,156 | 42.47B |
| 112 | HSIC | Henry Schein, Inc. | 9.45B | -0.32% | 473,782 | 13.60B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.40B | -2.12% | 363,754 | 105.00M |
| 114 | PODD | Insulet Corporation | 9.37B | -1.06% | 421,840 | 3.05B |
| 115 | BRKR | Bruker Corporation | 9.33B | 2.63% | 846,845 | 3.50B |
| 116 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.30B | -1.67% | 862,518 | 669.50M |
| 117 | GKOS | Glaukos Corporation | 9.16B | 1.24% | 288,953 | 612.84M |
| 118 | QGEN | Qiagen N.V. | 9.14B | 1.12% | 919,201 | 2.10B |
| 119 | CYTK | Cytokinetics, Incorporated | 9.12B | -0.32% | 818,662 | 67.67M |
| 120 | IBRX | ImmunityBio, Inc. | 8.96B | -2.03% | 4,583,801 | 165.79M |
| 121 | CAI | Caris Life Sciences, Inc. | 8.88B | -0.66% | 2,824,740 | 989.61M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.85B | -1.36% | 378,877 | 281.99M |
| 123 | OSCR | Oscar Health, Inc. | 8.84B | -6.09% | 3,348,263 | 15.32B |
| 124 | PCVX | Vaxcyte, Inc. | 8.43B | 0.22% | 860,178 | - |
| 125 | ABVX | ABIVAX Société Anonyme | 8.32B | -0.83% | 1,067,001 | 5.33M |
| 126 | TGTX | TG Therapeutics, Inc. | 7.99B | 0.64% | 635,592 | 799.54M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 7.82B | -0.73% | 322,553 | 7.46M |
| 128 | ATR | AptarGroup, Inc. | 7.80B | -1.61% | 151,614 | 3.93B |
| 129 | SYRE | Spyre Therapeutics, Inc. | 7.45B | -4.15% | 1,149,034 | - |
| 130 | HNGE | Hinge Health, Inc. | 7.38B | -0.88% | 1,063,556 | 720.06M |
| 131 | HQY | HealthEquity, Inc. | 7.31B | -2.26% | 391,109 | 1.36B |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.29B | -0.16% | 1,499,502 | 874.09M |
| 133 | IMVT | Immunovant, Inc. | 7.03B | -1.48% | 788,280 | - |
| 134 | ALKS | Alkermes plc | 6.86B | -2.91% | 998,557 | 1.67B |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 6.79B | 0.83% | 531,908 | 3.12B |
| 136 | BLTE | Belite Bio, Inc | 6.75B | -0.70% | 85,054 | - |
| 137 | HIMS | Hims & Hers Health, Inc. | 6.72B | 1.44% | 10,451,039 | 2.58B |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.68B | -1.17% | 320,588 | 239.92M |
| 139 | PACS | PACS Group, Inc. | 6.52B | 0.27% | 181,231 | 5.55B |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.51B | -0.16% | 420,805 | 1.56B |
| 141 | CHE | Chemed Corporation | 6.46B | -0.29% | 53,883 | 2.60B |
| 142 | GRFS | Grifols, S.A. | 6.39B | -0.14% | 247,909 | 8.48B |
| 143 | LQDA | Liquidia Corporation | 6.18B | 2.37% | 353,608 | 450.91M |
| 144 | CGON | CG Oncology, Inc. | 6.07B | -6.62% | 610,344 | 6.23M |
| 145 | BLCO | Bausch + Lomb Corporation | 6.04B | -0.79% | 51,989 | 5.32B |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 5.98B | 0.48% | 62,990 | 290.54M |
| 147 | SRRK | Scholar Rock Holding Corporation | 5.94B | -2.23% | 889,773 | - |
| 148 | BLLN | BillionToOne, Inc. | 5.84B | 8.16% | 533,650 | 397.41M |
| 149 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.83B | -1.81% | 164,707 | 840.85M |
| 150 | STVN | Stevanato Group S.p.A. | 5.83B | -1.66% | 85,965 | 1.40B |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 5.77B | -0.52% | 345,081 | 618.07M |
| 152 | MMED | MiniMed Group, Inc. | 5.73B | -0.78% | 1,585,922 | 3.22B |
| 153 | TVTX | Travere Therapeutics, Inc. | 5.71B | 1.27% | 707,458 | 591.33M |
| 154 | RDNT | RadNet, Inc. | 5.62B | -2.53% | 366,649 | 2.27B |
| 155 | ORKA | Oruka Therapeutics, Inc. | 5.60B | -5.93% | 825,636 | - |
| 156 | COGT | Cogent Biosciences, Inc. | 5.38B | -1.40% | 1,445,781 | - |
| 157 | CRSP | CRISPR Therapeutics AG | 5.31B | -1.60% | 839,030 | 13.39M |
| 158 | GRAL | GRAIL, Inc. | 5.28B | 8.99% | 2,135,452 | 165.26M |
| 159 | SHC | Sotera Health Company | 5.24B | 0.38% | 359,073 | 1.22B |
| 160 | MMSI | Merit Medical Systems, Inc. | 5.20B | -0.02% | 388,210 | 1.58B |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.15B | -0.95% | 748,168 | 1.01B |
| 162 | TFX | Teleflex Incorporated | 5.13B | -0.48% | 367,249 | 2.25B |
| 163 | DNTH | Dianthus Therapeutics, Inc. | 5.09B | -2.54% | 341,689 | 1.90M |
| 164 | DFTX | Definium Therapeutics, Inc. | 4.92B | -2.76% | 1,266,090 | - |
| 165 | ERAS | Erasca, Inc. | 4.91B | 0.75% | 2,526,970 | - |
| 166 | HAE | Haemonetics Corporation | 4.86B | -0.03% | 129,138 | 1.35B |
| 167 | MANE | Veradermics, Incorporated | 4.78B | -1.24% | 290,473 | - |
| 168 | IOVA | Iovance Biotherapeutics, Inc. | 4.70B | 1.86% | 5,420,601 | 324.97M |
| 169 | WAY | Waystar Holding Corp. | 4.69B | -1.21% | 425,766 | 1.21B |
| 170 | DOCS | Doximity, Inc. | 4.67B | -1.47% | 809,581 | 655.57M |
| 171 | ADPT | Adaptive Biotechnologies Corporation | 4.62B | 3.76% | 1,017,287 | 308.08M |
| 172 | LFST | LifeStance Health Group, Inc. | 4.58B | -0.87% | 1,682,790 | 1.58B |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.41B | -1.06% | 603,185 | - |
| 174 | CON | Concentra Group Holdings Parent, Inc. | 4.41B | -0.60% | 301,067 | 2.29B |
| 175 | ITGR | Integer Holdings Corporation | 4.30B | 0.04% | 202,951 | 1.84B |
| 176 | VKTX | Viking Therapeutics, Inc. | 4.19B | -13.81% | 20,569,913 | - |
| 177 | HTFL | HeartFlow, Inc. | 4.17B | 1.29% | 355,168 | 212.07M |
| 178 | ICUI | ICU Medical, Inc. | 4.15B | 1.52% | 153,776 | 2.16B |
| 179 | LIVN | LivaNova PLC | 4.14B | -2.53% | 469,730 | 1.47B |
| 180 | TNGX | Tango Therapeutics, Inc. | 4.05B | -1.72% | 1,010,081 | 53.81M |
| 181 | ABCL | AbCellera Biologics Inc. | 3.96B | -0.65% | 2,594,606 | 66.17M |
| 182 | ACAD | ACADIA Pharmaceuticals Inc. | 3.95B | -9.93% | 3,773,832 | 1.14B |
| 183 | PBLS | Parabilis Medicines, Inc. | 3.94B | -4.32% | 533,236 | 148.00K |
| 184 | CELC | Celcuity Inc. | 3.85B | -1.65% | 477,736 | - |
| 185 | NVST | Envista Holdings Corporation | 3.83B | 0.13% | 718,426 | 2.86B |
| 186 | RLAY | Relay Therapeutics, Inc. | 3.82B | -3.33% | 2,069,688 | 10.35M |
| 187 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.77B | -1.85% | 677,347 | -665.00K |
| 188 | VCYT | Veracyte, Inc. | 3.77B | 6.98% | 1,342,541 | 561.90M |
| 189 | PLSE | Pulse Biosciences, Inc. | 3.77B | 1.56% | 278,344 | 1.19M |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.75B | -0.80% | 469,512 | 890.79M |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.64B | -1.28% | 147,953 | 825.34M |
| 192 | XENE | Xenon Pharmaceuticals Inc. | 3.62B | 2.22% | 1,274,914 | 7.50M |
| 193 | OGN | Organon & Co. | 3.60B | -0.07% | 797,704 | 6.13B |
| 194 | LEGN | Legend Biotech Corporation | 3.56B | -0.43% | 643,109 | 1.27B |
| 195 | IDYA | IDEAYA Biosciences, Inc. | 3.53B | -2.27% | 658,620 | 234.13M |
| 196 | NHC | National HealthCare Corporation | 3.45B | -2.05% | 46,311 | 1.56B |
| 197 | OPCH | Option Care Health, Inc. | 3.44B | -1.67% | 449,024 | 5.69B |
| 198 | TARS | Tarsus Pharmaceuticals, Inc. | 3.32B | 1.84% | 223,978 | 606.33M |
| 199 | ELVN | Enliven Therapeutics, Inc. | 3.30B | -2.21% | 441,669 | - |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.26B | -1.67% | 1,095,179 | 463.98M |
| 201 | WRBY | Warby Parker Inc. | 3.23B | 11.99% | 3,212,310 | 911.61M |
| 202 | DNLI | Denali Therapeutics Inc. | 3.21B | -1.81% | 1,144,398 | 3.60M |
| 203 | CDNA | CareDx, Inc. | 3.21B | 14.16% | 1,311,324 | 458.09M |
| 204 | RCUS | Arcus Biosciences, Inc. | 3.18B | -5.27% | 726,137 | 117.00M |
| 205 | ATRC | AtriCure, Inc. | 3.11B | 2.06% | 518,552 | 569.62M |
| 206 | RGC | Regencell Bioscience Holdings Limited | 3.06B | 3.34% | 56,578 | - |
| 207 | DYN | Dyne Therapeutics, Inc. | 3.05B | 0.74% | 1,250,322 | - |
| 208 | NEOG | Neogen Corporation | 2.96B | -0.11% | 1,330,896 | 870.40M |
| 209 | TMDX | TransMedics Group, Inc. | 2.92B | -3.35% | 325,832 | 668.47M |
| 210 | ZLAB | Zai Lab Limited | 2.82B | -5.14% | 353,972 | 449.61M |
| 211 | AVAH | Aveanna Healthcare Holdings Inc. | 2.76B | -1.25% | 2,831,892 | 2.60B |
| 212 | PGEN | Precigen, Inc. | 2.72B | 2.08% | 1,958,306 | 85.72M |
| 213 | NAMS | NewAmsterdam Pharma Company N.V. | 2.68B | -1.15% | 389,259 | 7.12M |
| 214 | BKD | Brookdale Senior Living Inc. | 2.66B | -0.22% | 1,252,127 | 2.93B |
| 215 | GRDN | Guardian Pharmacy Services, Inc. | 2.65B | -3.12% | 182,104 | 1.46B |
| 216 | WGS | GeneDx Holdings Corp. | 2.64B | 3.76% | 1,088,648 | 454.43M |
| 217 | MBX | MBX Biosciences, Inc. | 2.63B | -5.61% | 290,474 | - |
| 218 | QURE | uniQure N.V. | 2.63B | -11.49% | 3,095,513 | 18.67M |
| 219 | IMNM | Immunome, Inc. | 2.57B | -6.60% | 1,303,295 | 4.02M |
| 220 | AXGN | Axogen, Inc. | 2.56B | 0.85% | 333,850 | 251.17M |
| 221 | ACHC | Acadia Healthcare Company, Inc. | 2.55B | -4.03% | 448,853 | 3.37B |
| 222 | IRON | Disc Medicine, Inc. | 2.51B | -1.16% | 219,271 | - |
| 223 | GPCR | Structure Therapeutics Inc. | 2.50B | -2.31% | 670,194 | - |
| 224 | SUPN | Supernus Pharmaceuticals, Inc. | 2.50B | -0.76% | 286,938 | 830.44M |
| 225 | HCM | HUTCHMED (China) Limited | 2.50B | -3.13% | 22,836 | 549.12M |
| 226 | NEO | NeoGenomics, Inc. | 2.47B | 4.85% | 874,125 | 766.30M |
| 227 | BFLY | Butterfly Network, Inc. | 2.45B | 0.11% | 2,990,613 | 112.14M |
| 228 | CLDX | Celldex Therapeutics, Inc. | 2.45B | 0.06% | 1,108,410 | 158.00K |
| 229 | PRVA | Privia Health Group, Inc. | 2.44B | - | 536,648 | 2.36B |
| 230 | BEAM | Beam Therapeutics Inc. | 2.44B | - | 1,325,060 | 156.04M |
| 231 | HRMY | Harmony Biosciences Holdings, Inc. | 2.41B | 2.37% | 387,258 | 959.90M |
| 232 | NRIX | Nurix Therapeutics, Inc. | 2.40B | -3.31% | 520,380 | 36.77M |
| 233 | CLOV | Clover Health Investments, Corp. | 2.37B | -2.30% | 1,748,899 | 2.48B |
| 234 | VERA | Vera Therapeutics, Inc. | 2.36B | -0.95% | 800,109 | - |
| 235 | TRLV | Trulieve Cannabis Corp. | 2.35B | -2.87% | 1,173,793 | 1.14B |
| 236 | MLYS | Mineralys Therapeutics, Inc. | 2.34B | -1.64% | 367,990 | - |
| 237 | UFPT | UFP Technologies, Inc. | 2.31B | 3.65% | 81,616 | 631.64M |
| 238 | SLS | SELLAS Life Sciences Group, Inc. | 2.30B | -1.22% | 2,516,232 | - |
| 239 | VRDN | Viridian Therapeutics, Inc. | 2.30B | -5.37% | 1,282,197 | 71.13M |
| 240 | ALMR | Alamar Biosciences, Inc. | 2.30B | 2.91% | 211,997 | 100.42M |
| 241 | PHVS | Pharvaris N.V. | 2.28B | -1.72% | 442,094 | - |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | 0.67% | 347,543 | 311.51M |
| 243 | SDGR | Schrödinger, Inc. | 2.17B | -0.89% | 1,167,309 | 259.04M |
| 244 | PBH | Prestige Consumer Healthcare Inc. | 2.17B | -0.39% | 282,022 | 1.10B |
| 245 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.16B | -1.46% | 2,740,258 | 940.61M |
| 246 | OCUL | Ocular Therapeutix, Inc. | 2.12B | -3.35% | 912,019 | 52.06M |
| 247 | ALVO | Alvotech | 2.12B | 2.32% | 665,594 | 494.61M |
| 248 | PVLA | Palvella Therapeutics, Inc. | 2.11B | -2.17% | 105,036 | - |
| 249 | ADMA | ADMA Biologics, Inc. | 2.11B | -2.99% | 1,294,948 | 512.28M |
| 250 | BHC | Bausch Health Companies Inc. | 2.09B | -2.28% | 853,599 | 10.85B |
| 251 | ADUS | Addus HomeCare Corporation | 2.09B | -0.82% | 59,747 | 1.48B |
| 252 | TRVI | Trevi Therapeutics, Inc. | 2.05B | -0.35% | 849,918 | - |
| 253 | PRGO | Perrigo Company plc | 2.05B | 6.79% | 4,980,218 | 4.14B |
| 254 | LKFT | Lakefront Biotherapeutics NV | 2.04B | -1.82% | 324,392 | 1.13B |
| 255 | MD | Pediatrix Medical Group, Inc. | 2.03B | -0.85% | 207,518 | 1.95B |
| 256 | URGN | UroGen Pharma Ltd. | 2.01B | -1.15% | 403,008 | 188.73M |
| 257 | INSP | Inspire Medical Systems, Inc. | 2.01B | 0.57% | 139,586 | 898.74M |
| 258 | GENB | Generate Biomedicines, Inc. | 2.01B | -5.36% | 695,273 | 26.48M |
| 259 | PGNY | Progyny, Inc. | 2.00B | 1.12% | 536,966 | 1.31B |
| 260 | MESO | Mesoblast Limited | 2.00B | 1.14% | 163,243 | 120.25M |
| 261 | RXRX | Recursion Pharmaceuticals, Inc. | 2.00B | 0.68% | 10,927,248 | 54.86M |
| 262 | BHVN | Biohaven Ltd. | 2.00B | -3.37% | 1,704,949 | - |
| 263 | VCEL | Vericel Corporation | 2.00B | 0.44% | 142,372 | 306.30M |
| 264 | NUVB | Nuvation Bio Inc. | 1.99B | -0.61% | 3,468,753 | 169.90M |
| 265 | NKTR | Nektar Therapeutics | 1.98B | 0.57% | 594,070 | 54.59M |
| 266 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | -3.19% | 968,135 | 98.34M |
| 267 | ESTA | Establishment Labs Holdings Inc. | 1.97B | -2.38% | 195,823 | 245.82M |
| 268 | KOD | Kodiak Sciences Inc. | 1.93B | -2.38% | 495,816 | - |
| 269 | SRPT | Sarepta Therapeutics, Inc. | 1.93B | -3.80% | 1,259,582 | 1.97B |
| 270 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.91B | -0.41% | 932,915 | 208.78M |
| 271 | ZYME | Zymeworks Inc. | 1.90B | -2.80% | 302,946 | 37.13M |
| 272 | XRAY | DENTSPLY SIRONA Inc. | 1.89B | -3.02% | 1,094,483 | 3.64B |
| 273 | FTRE | Fortrea Holdings Inc. | 1.89B | 1.79% | 336,204 | 2.68B |
| 274 | NVCR | NovoCure Limited | 1.88B | -0.74% | 389,594 | 699.19M |
| 275 | BLFS | BioLife Solutions, Inc. | 1.88B | 1.68% | 522,791 | 106.69M |
| 276 | LMAT | LeMaitre Vascular, Inc. | 1.83B | -0.65% | 140,131 | 262.43M |
| 277 | SGRY | Surgery Partners, Inc. | 1.82B | -3.71% | 781,777 | 3.37B |
| 278 | CMPS | COMPASS Pathways plc | 1.81B | -4.87% | 2,510,112 | - |
| 279 | SEPN | Septerna, Inc. | 1.78B | -0.61% | 88,992 | 98.88M |
| 280 | XNCR | Xencor, Inc. | 1.78B | -1.15% | 400,535 | 104.97M |
| 281 | VIR | Vir Biotechnology, Inc. | 1.78B | -5.14% | 914,253 | 303.23M |
| 282 | SNDA | Sonida Senior Living, Inc. | 1.78B | -0.58% | 167,939 | 481.07M |
| 283 | PSNL | Personalis, Inc. | 1.75B | 0.31% | 661,998 | 69.67M |
| 284 | NBTX | Nanobiotix S.A. | 1.75B | -6.36% | 136,746 | 38.27M |
| 285 | ASTH | Astrana Health, Inc. | 1.75B | -0.70% | 133,181 | 3.84B |
| 286 | NVAX | Novavax, Inc. | 1.73B | -0.76% | 2,293,707 | 413.80M |
| 287 | ZBIO | Zenas BioPharma, Inc. | 1.70B | -11.73% | 428,854 | 1.00M |
| 288 | FRNM | Freenome, Inc. | 1.70B | 0.51% | 204,401 | 35.41M |
| 289 | ABSI | Absci Corporation | 1.69B | 0.97% | 1,470,340 | 1.56M |
| 290 | NTLA | Intellia Therapeutics, Inc. | 1.68B | -2.92% | 2,742,636 | 59.51M |
| 291 | GHRS | GH Research PLC | 1.66B | -7.05% | 217,724 | - |
| 292 | STOK | Stoke Therapeutics, Inc. | 1.65B | -1.91% | 532,518 | 27.59M |
| 293 | COAG | Hemab Therapeutics Holdings, Inc. | 1.63B | -5.28% | 158,757 | - |
| 294 | ETON | Eton Pharmaceuticals, Inc. | 1.62B | 2.14% | 185,391 | 105.60M |
| 295 | IMCR | Immunocore Holdings plc | 1.60B | -1.46% | 332,296 | 430.78M |
| 296 | XERS | Xeris Biopharma Holdings, Inc. | 1.60B | 1.27% | 420,441 | 335.41M |
| 297 | ANIP | ANI Pharmaceuticals, Inc. | 1.59B | -0.30% | 111,868 | 978.38M |
| 298 | SNDX | Syndax Pharmaceuticals, Inc. | 1.57B | -0.40% | 764,029 | 252.25M |
| 299 | KLRA | Kailera Therapeutics, Inc. | 1.57B | -8.00% | 1,304,066 | - |
| 300 | RAPP | Rapport Therapeutics, Inc. | 1.57B | -4.37% | 511,274 | 20.00M |
| 301 | ALHC | Alignment Healthcare, Inc. | 1.56B | -4.07% | 10,398,042 | 4.58B |
| 302 | TSHA | Taysha Gene Therapies, Inc. | 1.53B | -4.07% | 3,333,858 | 5.49M |
| 303 | TYRA | Tyra Biosciences, Inc. | 1.53B | -3.96% | 355,229 | - |
| 304 | ATEC | Alphatec Holdings, Inc. | 1.53B | -1.20% | 552,433 | 815.05M |
| 305 | ANAB | AnaptysBio, Inc. | 1.53B | 0.78% | 191,536 | 106.09M |
| 306 | KMTS | Kestra Medical Technologies, Ltd. | 1.53B | 0.63% | 95,929 | 106.73M |
| 307 | KRSA | Korsana Biosciences, Inc. | 1.51B | 2.94% | 29,349 | - |
| 308 | MAZE | Maze Therapeutics, Inc. | 1.51B | -3.52% | 290,132 | 20.00M |
| 309 | INBX | Inhibrx Biosciences, Inc. | 1.49B | 0.94% | 168,806 | 1.30M |
| 310 | OMCL | Omnicell, Inc. | 1.49B | -0.97% | 148,957 | 1.25B |
| 311 | AZTA | Azenta, Inc. | 1.48B | -0.76% | 324,833 | 613.81M |
| 312 | INVA | Innoviva, Inc. | 1.48B | 1.33% | 376,160 | 440.00M |
| 313 | ARDT | Ardent Health, Inc. | 1.48B | -1.32% | 220,499 | 6.41B |
| 314 | OMER | Omeros Corporation | 1.47B | -2.12% | 361,139 | 38.42M |
| 315 | AVBP | ArriVent BioPharma, Inc. | 1.46B | -2.03% | 333,511 | - |
| 316 | HCSG | Healthcare Services Group, Inc. | 1.45B | -0.78% | 134,565 | 1.86B |
| 317 | BRVE | Braveheart Bio, Inc. | 1.44B | 2.70% | 165,820 | - |
| 318 | RARE | Ultragenyx Pharmaceutical Inc. | 1.44B | -1.65% | 1,710,628 | 717.00M |
| 319 | PNTG | The Pennant Group, Inc. | 1.38B | -0.43% | 153,680 | 1.10B |
| 320 | NUTX | Nutex Health Inc. | 1.37B | -0.55% | 89,585 | 846.72M |
| 321 | ORIC | ORIC Pharmaceuticals, Inc. | 1.37B | -1.09% | 949,755 | - |
| 322 | AAPG | Ascentage Pharma Group International | 1.36B | -3.40% | 13,752 | 94.61M |
| 323 | PAHC | Phibro Animal Health Corporation | 1.36B | -2.02% | 53,538 | 1.52B |
| 324 | CNMD | CONMED Corporation | 1.35B | -1.35% | 99,665 | 1.37B |
| 325 | AMN | AMN Healthcare Services, Inc. | 1.34B | 1.65% | 256,951 | 3.43B |
| 326 | KARD | Kardigan, Inc. | 1.33B | -1.79% | 410,554 | - |
| 327 | CERT | Certara, Inc. | 1.33B | 0.93% | 551,586 | 421.75M |
| 328 | DRTS | Alpha Tau Medical Ltd. | 1.33B | -0.86% | 136,550 | - |
| 329 | BCAX | Bicara Therapeutics Inc. | 1.30B | -4.37% | 803,605 | - |
| 330 | SVRA | Savara Inc. | 1.28B | 0.50% | 1,375,235 | - |
| 331 | TRAX | First Tracks Biotherapeutics, Inc. | 1.28B | -2.62% | 686,849 | - |
| 332 | USPH | U.S. Physical Therapy, Inc. | 1.26B | 2.03% | 77,893 | 804.27M |
| 333 | CRON | Cronos Group Inc. | 1.26B | -1.76% | 489,659 | 179.09M |
| 334 | AGL | agilon health, inc. | 1.24B | -12.38% | 154,300 | 5.92B |
| 335 | HROW | Harrow, Inc. | 1.24B | -1.65% | 205,435 | 275.59M |
| 336 | AVLN | Avalyn Pharma Inc. | 1.23B | -6.72% | 103,605 | - |
| 337 | DMRA | Damora Therapeutics, Inc. | 1.23B | -2.79% | 483,341 | - |
| 338 | OPK | OPKO Health, Inc. | 1.22B | -3.53% | 1,935,728 | 587.90M |
| 339 | LBRX | LB Pharmaceuticals Inc | 1.22B | -3.55% | 164,036 | - |
| 340 | IART | Integra LifeSciences Holdings Corporation | 1.22B | 0.84% | 223,926 | 1.65B |
| 341 | OMDA | Omada Health, Inc. | 1.22B | -3.87% | 398,634 | 309.76M |
| 342 | LTGO | Latigo Biotherapeutics, Inc. | 1.21B | -8.61% | 185,923 | - |
| 343 | INNV | InnovAge Holding Corp. | 1.19B | -3.00% | 725,098 | 989.71M |
| 344 | REPL | Replimune Group, Inc. | 1.17B | -4.48% | 1,004,675 | - |
| 345 | BBNX | Beta Bionics, Inc. | 1.15B | -1.17% | 349,075 | 119.01M |
| 346 | GDRX | GoodRx Holdings, Inc. | 1.14B | 0.45% | 538,443 | 785.23M |
| 347 | BVS | Bioventus Inc. | 1.13B | -1.25% | 81,355 | 581.85M |
| 348 | AORT | Artivion, Inc. | 1.13B | -1.57% | 193,639 | 471.47M |
| 349 | IMTX | Immatics N.V. | 1.12B | -4.77% | 1,945,928 | 47.65M |
| 350 | SPTX | Seaport Therapeutics, Inc. | 1.11B | -2.96% | 34,145 | - |
| 351 | TDOC | Teladoc Health, Inc. | 1.10B | -0.82% | 1,126,491 | 2.49B |
| 352 | IRMD | IRADIMED CORPORATION | 1.09B | -1.22% | 84,393 | 86.34M |
| 353 | AKTS | Aktis Oncology, Inc. | 1.09B | -0.91% | 206,281 | 10.06M |
| 354 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.08B | 2.04% | 226,875 | 730.02M |
| 355 | VOR | Vor Biopharma Inc. | 1.08B | -5.89% | 1,272,483 | - |
| 356 | MGTX | MeiraGTx Holdings plc | 1.07B | -5.11% | 645,455 | 397.50M |
| 357 | TNDM | Tandem Diabetes Care, Inc. | 1.06B | -6.65% | 1,162,179 | 1.04B |
| 358 | ANRO | Alto Neuroscience, Inc. | 1.06B | -2.20% | 511,964 | - |
| 359 | MNKD | MannKind Corporation | 1.05B | -2.10% | 1,455,765 | 393.63M |
| 360 | CSTL | Castle Biosciences, Inc. | 1.05B | -1.92% | 168,314 | 357.28M |
| 361 | MLTX | MoonLake Immunotherapeutics | 1.04B | -5.43% | 937,827 | - |
| 362 | ENOV | Enovis Corporation | 1.02B | -2.91% | 591,208 | 2.30B |
| 363 | CGEM | Cullinan Therapeutics, Inc. | 1.02B | -6.37% | 1,647,966 | - |
| 364 | PRCT | PROCEPT BioRobotics Corporation | 1.00B | -3.43% | 463,803 | 337.34M |
| 365 | JANX | Janux Therapeutics, Inc. | 996.53M | -1.33% | 566,635 | 24.00M |
| 366 | GLUE | Monte Rosa Therapeutics, Inc. | 996.46M | -1.77% | 482,691 | 28.73M |
| 367 | ANL | Adlai Nortye Group Ltd. | 989.80M | -2.41% | 86,170 | 18.06M |
| 368 | CRVS | Corvus Pharmaceuticals, Inc. | 983.79M | -6.74% | 618,986 | - |
| 369 | PCRX | Pacira BioSciences, Inc. | 982.00M | 0.02% | 156,308 | 746.16M |
| 370 | KURA | Kura Oncology, Inc. | 968.78M | -1.36% | 824,402 | 77.23M |
| 371 | STAA | STAAR Surgical Company | 968.53M | -2.45% | 255,175 | 339.59M |
| 372 | ABUS | Arbutus Biopharma Corporation | 962.53M | 0.31% | 4,086,727 | 181.72M |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 961.71M | -1.28% | 192,215 | 1.04B |
| 374 | ALMS | Alumis Inc. | 956.53M | -0.67% | 1,222,937 | 7.40M |
| 375 | JBIO | Jade Biosciences, Inc. | 943.47M | 0.85% | 561,399 | - |
| 376 | SGP | SpyGlass Pharma, Inc. | 912.80M | -3.09% | 46,962 | - |
| 377 | CBLL | CeriBell, Inc. | 911.48M | 0.55% | 94,168 | 101.96M |
| 378 | HELP | Cybin Inc. | 905.95M | -4.76% | 945,828 | - |
| 379 | ODTX | Odyssey Therapeutics, Inc. | 904.22M | -9.10% | 188,859 | 99.00K |
| 380 | RIGL | Rigel Pharmaceuticals, Inc. | 887.29M | -1.31% | 46,208 | 276.79M |
| 381 | TBPH | Theravance Biopharma, Inc. | 884.18M | - | - | 104.31M |
| 382 | SLBT | SL Science Holding Limited | 881.63M | -6.87% | 66,599 | 3.27M |
| 383 | HSTM | HealthStream, Inc. | 879.78M | -0.02% | 36,687 | 321.12M |
| 384 | SANA | Sana Biotechnology, Inc. | 874.13M | -5.19% | 1,987,131 | - |
| 385 | APMD | Apnimed, Inc. | 860.72M | -8.07% | 196,488 | 115.12M |
| 386 | ARDX | Ardelyx, Inc. | 858.45M | -1.01% | 1,807,192 | 450.89M |
| 387 | OBX | Obsidian Therapeutics, Inc. | 856.79M | -9.11% | 158,335 | - |
| 388 | CADL | Candel Therapeutics, Inc. | 853.95M | -1.15% | 451,506 | - |
| 389 | ATTO | Attovia Therapeutics, Inc. | 845.00M | -0.05% | 108,121 | 1.80M |
| 390 | GMRS | GMR Solutions Inc. | 835.51M | -2.27% | 405,137 | 5.88B |
| 391 | LXRX | Lexicon Pharmaceuticals, Inc. | 834.29M | -8.98% | 2,792,618 | 41.47M |
| 392 | IMMX | Immix Biopharma, Inc. | 828.43M | -2.85% | 673,340 | - |
| 393 | SIBN | SI-BONE, Inc. | 828.25M | -0.65% | 331,723 | 213.60M |
| 394 | INMD | InMode Ltd. | 815.08M | -0.07% | 201,283 | 374.63M |
| 395 | AVTX | Avalo Therapeutics, Inc. | 810.35M | -1.24% | 773,344 | 59.00K |
| 396 | IVA | Inventiva S.A. | 807.61M | -9.13% | 1,442,010 | 7.94M |
| 397 | GERN | Geron Corporation | 806.30M | 1.21% | 3,200,435 | 204.56M |
| 398 | SLDB | Solid Biosciences Inc. | 798.83M | -7.11% | 748,047 | - |
| 399 | ACHV | Achieve Life Sciences, Inc. | 795.44M | -1.28% | 461,511 | - |
| 400 | ETRA | Electra Therapeutics, Inc. | 784.90M | -1.30% | 197,636 | - |
| 401 | VREX | Varex Imaging Corporation | 778.68M | 0.14% | 420,033 | 865.00M |
| 402 | FDMT | 4D Molecular Therapeutics, Inc. | 775.08M | -6.47% | 1,170,634 | 92.01M |
| 403 | OLMA | Olema Pharmaceuticals, Inc. | 773.92M | 0.17% | 649,389 | - |
| 404 | ACRS | Aclaris Therapeutics, Inc. | 772.06M | -0.29% | 1,087,547 | 8.22M |
| 405 | WVE | Wave Life Sciences, Inc. | 768.49M | -1.27% | 1,862,684 | 65.37M |
| 406 | GYRE | Gyre Therapeutics, Inc. | 762.38M | -2.84% | 143,225 | 109.82M |
| 407 | DSGN | Design Therapeutics, Inc. | 753.48M | -2.59% | 221,535 | - |
| 408 | AHCO | AdaptHealth Corp. | 747.76M | -1.67% | 906,480 | 3.36B |
| 409 | AVR | Anteris Technologies Global Corp. | 746.53M | 0.52% | 413,680 | 2.24M |
| 410 | DBVT | DBV Technologies S.A. | 735.66M | -7.31% | 250,413 | 5.04M |
| 411 | FTH | Faeth Therapeutics, Inc. | 735.16M | -9.83% | 397,155 | - |
| 412 | COLL | Collegium Pharmaceutical, Inc. | 734.45M | 0.49% | 275,902 | 808.21M |
| 413 | PHAR | Pharming Group N.V. | 734.34M | -2.27% | 26,511 | 366.48M |
| 414 | CTKB | Cytek Biosciences, Inc. | 733.76M | -0.62% | 679,412 | 206.71M |
| 415 | QDEL | QuidelOrtho Corporation | 724.84M | 2.22% | 482,742 | 2.67B |
| 416 | ANNX | Annexon, Inc. | 724.19M | -1.29% | 885,718 | - |
| 417 | VSTM | Verastem, Inc. | 707.75M | -4.46% | 717,511 | 87.53M |
| 418 | MDXG | MiMedx Group, Inc. | 691.63M | -0.52% | 351,184 | 355.17M |
| 419 | SLN | Silence Therapeutics plc | 688.19M | -0.70% | 431,373 | 615.00K |
| 420 | OABI | OmniAb, Inc. | 684.79M | -1.67% | 379,651 | 38.46M |
| 421 | NVCT | Nuvectis Pharma, Inc. | 684.21M | -0.33% | 126,048 | - |
| 422 | GLAS | Glass House Brands Inc. | 684.20M | -7.52% | 1,039,615 | 176.98M |
| 423 | SOPH | SOPHiA GENETICS SA | 683.58M | -0.62% | 130,622 | 86.17M |
| 424 | IRWD | Ironwood Pharmaceuticals, Inc. | 680.79M | -3.51% | 744,439 | 389.32M |
| 425 | CLYM | Climb Bio, Inc. | 667.41M | -7.19% | 921,423 | - |
| 426 | BLSM | BlossomHill Therapeutics, Inc. | 661.92M | -6.78% | 153,323 | - |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 661.54M | -1.59% | 192,703 | 136.07M |
| 428 | STLN | Starling Oncology, Inc. | 652.77M | -6.09% | 752,489 | 587.24M |
| 429 | ANGO | AngioDynamics, Inc. | 639.83M | -0.19% | 149,412 | 320.17M |
| 430 | DNA | Ginkgo Bioworks Holdings, Inc. | 639.06M | 10.61% | 2,101,990 | 132.42M |
| 431 | AHG | Akso Health Group | 633.96M | -3.88% | 4,393 | 13.83M |
| 432 | AURA | Aura Biosciences, Inc. | 632.60M | 1.33% | 589,243 | - |
| 433 | STTK | Shattuck Labs, Inc. | 630.28M | -1.26% | 555,007 | 1.00M |
| 434 | NGNE | Neurogene Inc. | 624.24M | 0.85% | 200,920 | 925.00K |
| 435 | PHR | Phreesia, Inc. | 606.43M | 0.93% | 277,307 | 507.79M |
| 436 | CBIO | Crescent Biopharma, Inc. | 605.64M | -0.28% | 275,407 | 11.88M |
| 437 | VALN | Valneva SE | 601.98M | -2.44% | 29,232 | 163.30M |
| 438 | CRMD | CorMedix Inc. | 596.27M | -0.52% | 335,876 | 462.25M |
| 439 | FLGT | Fulgent Genetics, Inc. | 596.26M | 1.88% | 121,756 | 323.93M |
| 440 | ALT | Altimmune, Inc. | 593.28M | -4.39% | 2,415,817 | 31.00K |
| 441 | MPLT | MapLight Therapeutics, Inc. | 593.20M | -0.89% | 187,995 | - |
| 442 | CTMX | CytomX Therapeutics, Inc. | 592.69M | -2.16% | 1,531,092 | 18.30M |
| 443 | AQST | Aquestive Therapeutics, Inc. | 591.79M | 0.32% | 1,913,820 | 54.09M |
| 444 | KIDS | OrthoPediatrics Corp. | 588.25M | 0.90% | 39,391 | 252.72M |
| 445 | WEAV | Weave Communications, Inc. | 587.59M | -0.20% | 490,798 | 257.79M |
| 446 | SSII | SS Innovations International, Inc. | 585.13M | -6.11% | 63,393 | 52.40M |
| 447 | MNPR | Monopar Therapeutics Inc. | 585.03M | -2.48% | 102,825 | - |
| 448 | OCS | Oculis Holding AG | 582.13M | -5.61% | 133,651 | 1.45M |
| 449 | DRUG | Bright Minds Biosciences Inc. | 570.62M | -4.64% | 54,492 | - |
| 450 | ALLO | Allogene Therapeutics, Inc. | 566.61M | -1.80% | 3,620,508 | 4.64M |
| 451 | TLRY | Tilray Brands, Inc. | 557.56M | -0.97% | 1,281,046 | 915.45M |
| 452 | EVO | Evotec SE | 556.53M | -1.30% | 19,047 | 819.47M |
| 453 | PHAT | Phathom Pharmaceuticals, Inc. | 554.42M | -0.07% | 419,219 | 239.66M |
| 454 | BWAY | BrainsWay Ltd. | 549.29M | -1.26% | 35,815 | 60.70M |
| 455 | DCTH | Delcath Systems, Inc. | 544.77M | -1.63% | 107,601 | 95.42M |
| 456 | PRME | Prime Medicine, Inc. | 544.39M | -2.24% | 1,499,991 | 4.07M |
| 457 | SGMT | Sagimet Biosciences Inc. | 543.89M | -16.03% | 2,134,694 | - |
| 458 | INDP | Indaptus Therapeutics, Inc. | 538.30M | 7.16% | 369,630 | - |
| 459 | SENS | Senseonics Holdings, Inc. | 537.20M | 1.85% | 369,988 | 48.55M |
| 460 | EPRX | Eupraxia Pharmaceuticals Inc. | 535.37M | -0.49% | 212,351 | - |
| 461 | CERS | Cerus Corporation | 523.96M | - | 933,106 | 221.55M |
| 462 | EOLS | Evolus, Inc. | 521.80M | -1.25% | 142,272 | 316.49M |
| 463 | AGMB | AgomAb Therapeutics NV | 519.57M | -2.00% | 32,554 | - |
| 464 | TCMD | Tactile Systems Technology, Inc. | 517.83M | 1.92% | 81,945 | 350.31M |
| 465 | KMDA | Kamada Ltd. | 504.49M | 0.63% | 48,364 | 191.85M |
| 466 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 467 | AUTL | Autolus Therapeutics plc | 503.05M | -3.08% | 966,285 | 117.39M |
| 468 | CAPR | Capricor Therapeutics, Inc. | 497.09M | -1.38% | 1,054,350 | 11.13M |
| 469 | TKNO | Alpha Teknova, Inc. | 495.54M | 3.36% | 184,384 | 43.70M |
| 470 | PBYI | Puma Biotechnology, Inc. | 494.00M | 3.13% | 205,519 | 231.24M |
| 471 | ENTX | Entera Bio Ltd. | 492.59M | 1.25% | 145,123 | 42.00K |
| 472 | PROK | ProKidney Corp. | 489.76M | -1.82% | 723,224 | 818.00K |
| 473 | ARVN | Arvinas, Inc. | 486.47M | -4.98% | 325,089 | 316.70M |
| 474 | NPCE | NeuroPace, Inc. | 483.63M | -0.84% | 93,071 | 106.99M |
| 475 | ASMB | Assembly Biosciences, Inc. | 482.55M | -1.13% | 70,476 | 74.85M |
| 476 | SGHT | Sight Sciences, Inc. | 482.23M | 2.99% | 151,187 | 83.38M |
| 477 | OVID | Ovid Therapeutics Inc. | 479.46M | -4.47% | 900,865 | 1.58M |
| 478 | RGNX | REGENXBIO Inc. | 473.31M | -4.40% | 616,579 | 174.48M |
| 479 | TECX | Tectonic Therapeutic, Inc. | 467.43M | -4.28% | 97,688 | - |
| 480 | SRTA | Strata Critical Medical, Inc. | 465.34M | -2.23% | 287,154 | 255.98M |
| 481 | MASS | 908 Devices Inc. | 462.11M | 2.19% | 122,193 | 60.84M |
| 482 | PACB | Pacific Biosciences of California, Inc. | 458.48M | 4.61% | 4,930,280 | 159.27M |
| 483 | NRC | NRC Health | 457.43M | -4.13% | 49,416 | 140.00M |
| 484 | CTNM | Contineum Therapeutics, Inc. | 441.86M | -6.12% | 257,087 | - |
| 485 | CLPT | ClearPoint Neuro, Inc. | 439.26M | -3.81% | 418,338 | 42.28M |
| 486 | EIKN | Eikon Therapeutics, Inc. | 432.24M | -1.85% | 268,854 | - |
| 487 | PRTA | Prothena Corporation plc | 429.69M | -3.57% | 190,558 | 54.53M |
| 488 | KYTX | Kyverna Therapeutics, Inc. | 426.10M | -2.55% | 2,638,111 | - |
| 489 | SCTX | Scribe Therapeutics Inc. | 420.85M | -16.21% | 325,244 | 33.30M |
| 490 | DMAC | DiaMedica Therapeutics Inc. | 419.54M | 2.91% | 88,990 | - |
| 491 | AVIR | Atea Pharmaceuticals, Inc. | 419.47M | -0.95% | 90,663 | - |
| 492 | SPRY | ARS Pharmaceuticals, Inc. | 411.21M | -1.08% | 498,841 | 116.93M |
| 493 | CTEV | Claritev Corporation | 410.98M | -3.15% | 59,340 | 994.67M |
| 494 | RZLT | Rezolute, Inc. | 410.55M | -1.75% | 2,912,454 | - |
| 495 | EDIT | Editas Medicine, Inc. | 410.06M | -0.74% | 1,715,278 | 47.01M |
| 496 | CGC | Canopy Growth Corporation | 405.17M | 0.79% | 1,080,338 | 206.77M |
| 497 | PRLD | Prelude Therapeutics Incorporated | 404.77M | -8.82% | 331,432 | 22.42M |
| 498 | RLMD | Relmada Therapeutics, Inc. | 404.28M | 0.26% | 854,591 | - |
| 499 | CARL | Carlsmed, Inc. | 402.99M | - | 24,741 | 63.30M |
| 500 | MYGN | Myriad Genetics, Inc. | 401.73M | 4.74% | 697,149 | 806.60M |